.anton Osyntsov

Dr. .anton Osyntsov


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GBGuy Barsky
Guy Barsky
GHGrace Haj
Grace Haj
.O.anton Osyntsov
.anton Osyntsov
IKIvan Kukeev
Ivan Kukeev
JVJulie Vaynshtein
Julie Vaynshtein
DCDavid Czeiger
David Czeiger

Background: Anastomotic leakage remains a serious complication following colorectal surgery, often associated with significant morbidity and mortality. Impaired blood supply at the incision site has been suggested as a key contributing factor. Objective: To develop and validate a reproducible rat model of colonic anastomotic leakage induced by graded mesocolon ischemia at the incision margins. Methods: 144 rats underwent end-to-end colonic anastomosis with five different levels of mesocolon ligation, ranging from no ligation (control) to 2 cm ischemia on each side. Postoperative outcomes, including anastomotic integrity, abscess formation, and mortality, were assessed 10 days postoperatively. Results: Anastomotic leak rates increased proportionally with the extent of mesocolic ischemia: 0% in controls, 19.04% with 0.2 cm ligation, 44.23% with 0.4 cm, and 100% with 1 and 2 cm. The model was consistent and reproducible. Conclusions: This model reliably induces graded anastomotic leaks in rats and may serve as a platform for future studies evaluating interventions to reduce leak risk in high-risk colorectal surgery patients.


10 April 2026 in Surgeries
Verified
Journal Article
Open access
PDF file
GBGuy Barsky
Guy Barsky
GHGrace Haj
Grace Haj
.O.anton Osyntsov
.anton Osyntsov
IKIvan Kukeev
Ivan Kukeev
YVYulia Vaynshtein
Yulia Vaynshtein
DCDavid Czeiger
David Czeiger
Background: Anastomotic leakage remains a serious complication of colorectal surgery, often linked to impaired blood supply at the incision site. Objective: To develop and validate a reproducible rat model of colonic anastomotic leakage induced by graded mesocolon ischemia. Methods: Of 144 operated rats, 138 survived surgery and underwent end-to-end colonic anastomosis with five levels of mesocolon ligation (0–2 cm of unilateral mesocolic ischemia). Postoperative outcomes, including anastomotic integrity, abscess formation, and mortality, were assessed on postoperative day 10. Anastomotic bursting pressures were also measured in a subset of animals. Results: Leak rates increased with ischemia severity: 0% in controls, 16.7% at 0.2 cm, 42.6% at 0.4 cm, 95.8% at 1 cm, and 100% at 2 cm (p < 0.0001, trend test). Bursting pressures decreased progressively with increasing anastomotic severity. The 0.4 cm ischemia condition produced a reproducible intermediate leak rate suitable for experimental interventions. Conclusions: This rat model reliably induces graded anastomotic leaks and can serve as a platform for testing strategies to prevent leakage in high-risk colorectal surgery.

4 November 2026 in International Journal of Surgery
Verified
Journal Article
Open access
NANur Alkrinawi
Nur Alkrinawi
SFSofyan Abu Freih
Sofyan Abu Freih
YAYuval Arnon
Yuval Arnon
ASAbu-Swis Shadi
Abu-Swis Shadi
AVAlex Vakhrushev
Alex Vakhrushev
ODOleg Dukhno
Oleg Dukhno
Background: The prevalence of patients with extreme obesity [body mass index (BMI) ≥ 50] has significantly increased over the past three decades, surpassing the rise in the prevalence of overweight individuals in the general population. Ring-augmented one-anastomosis gastric bypass (RA-OAGB) is a modification of standard one-anastomosis gastric bypass (OAGB) designed to enhance the durability of long-term weight-loss and potentially reduce pouch dilation, particularly in patients with extreme obesity. While short-term outcomes appear comparable to other procedures, long-term comparative data remain limited. Methods: In this retrospective single-center study, we compared patients who underwent RA-OAGB with those who underwent OAGB or sleeve gastrectomy (SG) procedures, all with a minimum follow-up of ≥5 years. Data collected included demographics, comorbidities, perioperative outcomes, long-term complications, and patient-reported quality of life. Results: A total of 111 patients were included in our study during the study period – 24 underwent RA-OAGB, 44 OAGB, and 43 SG. Loss to direct follow-up at 5 years was 15% (94/111 patients had direct follow-up), although clinical data were available for all patients through medical records. The RA-OAGB group had a higher baseline BMI than the OAGB and SG groups (55.4 vs. 51.2 and 51.3 kg/m 2 ; P = 0.006). In the unadjusted analysis, median percentage of excess weight loss (%EWL) was 74%, 63%, and 52%, respectively ( P = 0.027), while median percentage of total weight loss (%TWL) was 42.4%, 37.5%, and 28.9%, respectively ( P = 0.017). After adjustment for baseline BMI and follow-up duration, BMI was significantly lower after RA-OAGB compared with SG ( P = 0.025); RA-OAGB remained associated with greater %EWL ( P = 0.001) and %TWL ( P = 0.002) compared with SG. Adjusted associations with symptomatic gastroesophageal reflux disease (GERD) were not statistically significant. Iron-deficiency anemia was more frequent after bypass procedures than after SG. Quality of life and patient satisfaction were high across all groups, with no significant differences in Bariatric Analysis and Reporting Outcome System (BAROS) scores. Conclusion: In this retrospective single-center study, RA-OAGB was associated with greater long-term weight loss than OAGB and SG. However, given the observational design, baseline differences between groups, and limited sample size, these findings should be considered hypothesis-generating and require confirmation in larger prospective multicenter studies.

26 May 2026 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
NANur Alkrinawi
Nur Alkrinawi
SFSofyan Abu Freih
Sofyan Abu Freih
GBGuy Barsky
Guy Barsky
.O.anton Osyntsov
.anton Osyntsov
GSGadi Shaked
Gadi Shaked
Introduction and importance: Traumatic rupture of hepatic hydatid cysts is a rare but life-threatening complication of echinococcal disease. Rupture following blunt abdominal trauma can lead to anaphylaxis, massive peritoneal contamination, and rapid hemodynamic deterioration. Early recognition is essential, especially in endemic regions. Case presentation: A 19-year-old, previously healthy male sustained polytrauma in a high-speed motor vehicle accident. Initial assessment showed a Glasgow Coma Scale of 3 and a fixed left pupil. Computed tomography demonstrated a left subdural hemorrhage and bilateral subarachnoid hemorrhages (Fig. 1A), a traumatic rupture of a hepatic hydatid cyst with peritoneal spillage (Fig. 1B), a suspected jejunal injury, hemoperitoneum, and an L4 vertebral fracture (Fig. 1C). The patient underwent emergent exploratory laparotomy with evacuation of daughter cysts, cyst unroofing, hypertonic saline lavage, and repair of a jejunal laceration, as well as decompressive craniectomy. Despite aggressive resuscitation and critical care, the patient developed refractory intracranial hypertension and died on postoperative day two, primarily due to severe traumatic brain injury, with hydatid cyst rupture contributing to the overall clinical complexity. JOURNAL/ijscr/04.03/01612930-202606000-00048/figure1/v/2026-07-06T122116Z/r/image-jpeg Clinical discussion: Traumatic rupture of hepatic hydatid cysts is uncommon but is associated with significant morbidity and mortality. Diagnosis may be delayed in polytrauma patients due to competing injuries that obscure clinical signs. Peritoneal dissemination may result in anaphylaxis, sepsis, and recurrence. Even with timely surgical intervention, outcomes are often determined by associated life-threatening injuries, such as severe traumatic brain injury, as in this case. Conclusion: Traumatic rupture of hepatic hydatid cysts should be considered in patients with blunt abdominal trauma in endemic regions. Early imaging, prompt surgical intervention, and a high index of suspicion are crucial. In polytrauma patients, this significantly complicates clinical prioritization and may determine prognosis, even when abdominal contamination is surgically controlled.

23 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
EKEster Noy Machluf Katz
Ester Noy Machluf Katz
SSSami Stalin
Sami Stalin
GBGuy Barsky
Guy Barsky
LMLelyan Moadi
Lelyan Moadi
AWAriel Weiner
Ariel Weiner
EVElena -- Voronov
Elena -- Voronov
(1) Background: Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. The tumor microenvironment (TME) is a key driver of disease progression, shaping both pro- and anti-tumor immune responses. Interleukin-1β (IL-1β) is a pleiotropic pro-inflammatory cytokine that participates in both homeostatic and pathological conditions. It has been shown to be upregulated in many tumors, including CRC, where it promotes angiogenesis, immunosuppression, and resistance to chemotherapy. (2) Objective: Elucidate the correlation between TME IL-1β and colon microbiotic changes during CRC progression and approach inhibition of IL-1β as a therapeutic strategy in combination with chemotherapy. (3) Design: Using an orthotopic mouse model of CRC, we compared tumor growth, metastatic spread, immune infiltration and microbiome composition in control and IL-1β knockout mice. In addition, we studied the effects of IL-1β neutralization alone or in combination with FOLFOX chemotherapy on CRC prognosis. (4) Results: IL-1β promoted CRC progression by enhancing pro-inflammatory signalling, recruiting immunosuppressive myeloid cells, and driving microbiome dysbiosis. In contrast, IL-1β deficiency increased antigen-presenting myeloid cells and CD8+ T-cell infiltration, leading to delayed tumor growth and reduced metastasis. FOLFOX chemotherapy alone exacerbated systemic and local inflammation, facilitating liver metastasis. Strikingly, the addition of IL-1β blockade abrogated FOLFOX-induced inflammation, enhanced anti-tumor immunity, and prevented metastatic spread. (5) Conclusions: IL-1β from the TME links microbiome dysbiosis, tumor-promoting inflammation and poor chemotherapy outcomes in CRC. Combining IL-1β inhibition with standard FOLFOX chemotherapy represents a promising therapeutic approach to improve prognosis in CRC patients.